Metraipolis › archive › dc_2eeb187bd841
Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42579028
- DOI
- 10.1007/s10147-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T07:52:04.853Z
- SHA-256 of the archived text
0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9- Stable URL of this page
https://metraipolis.com/documento/dc_2eeb187bd841
How to cite
Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028 — Europe PMC (en), https://europepmc.org/article/MED/42579028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eeb187bd841 (Metraipolis archive dc_2eeb187bd841, sha256 0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9)
BibTeX
@misc{dc2eeb187bd841,
title = {Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42579028},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eeb187bd841; sha256 0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42579028. Agents can read the archived copy with the MCP tool read_document.